Riskpilot
← Back to search
Sign in
Get full access
RW- Clinical Trials AB
AB
In liquidation
Org 5568919327
General medical practice activities
· NACE 8621
Est. 2012
0 employees
Watchlist
Share
Sweden
/
Companies
/
General medical practice activities
/
RW- Clinical Trials AB
Overview
Financials
People & ownership
Related companies
Loading company…
Revenue 2019
SEK 0
EBITDA margin
—
+90% vs 2018
Equity ratio
28.0%
Financial strength
Net profit 2019
SEK -7K
+90% vs 2018
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2015
0M
0%
2016
0M
0%
2017
0M
0%
2018
0M
0%
2019
Key figures
Annual report 2019
Revenue
SEK 0
—
EBITDA
SEK -7K
+90%
Net profit
SEK -7K
+90%
Total assets
SEK 182K
+0%
Equity
SEK 51K
-12%
Employees
0
—
Company information
Legal name
RW- Clinical Trials AB
Org number
5568919327
Legal form
Aktiebolag
NACE code
8621 ·
General medical practice activities
Founded
2 maj 2012
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2019-12-31
Financial year
January – December
Company purpose
Forskning inom medicin.
Contact
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in
All Sweden companies
Frequently asked questions
What is the Org number of RW- Clinical Trials AB?
RW- Clinical Trials AB is registered with Bolagsverket / SCB under Org 5568919327.
Who is the CEO of RW- Clinical Trials AB?
Maria Ihlar Lindahl is Liquidator of RW- Clinical Trials AB, in role since 2021.